lézerterápia

Lézerterápia, often referred to as low-level laser therapy (LLLT) or photobiomodulation, is a non-invasive medical treatment that uses specific wavelengths of light to stimulate cellular processes. The laser device, typically handheld, emits photons that are absorbed by cellular chromophores, particularly in the mitochondria. This absorption is believed to trigger a cascade of photochemical and photophysical reactions within the cells.

The primary proposed mechanisms of action involve increasing adenosine triphosphate (ATP) production, reducing oxidative stress, and modulating inflammatory responses. By enhancing cellular energy production and promoting repair mechanisms, lézerterápia aims to accelerate healing, reduce pain, and decrease inflammation in various tissues. The specific wavelengths and dosages used are crucial for achieving the desired therapeutic effects, with different wavelengths penetrating tissues to varying depths and targeting different cellular components.

Lézerterápia has found applications in a range of medical fields, including physical therapy, sports medicine, dermatology, and dentistry. It is commonly used to manage musculoskeletal pain, accelerate wound healing, treat skin conditions, and alleviate symptoms associated with certain inflammatory diseases. While many studies suggest positive outcomes, ongoing research continues to explore its efficacy and optimal parameters for different conditions. It is generally considered safe when administered by trained professionals, with minimal reported side effects.